TRIM Interactions with Arthritic Alphaviruses
TRIM Interactions with Arthritic Alphaviruses
批准号:
8415508
负责人:
Mark T Heise
金额:
$18.19万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-01 至 2015-01-31
关键词:
AcuteAffectAlphavirusAntiviral AgentsArthritisBiological AssayBypassCellsChikungunya virusComplexDevelopmentDiseaseFamily memberFibroblastsHIVHumanIFN consensus sequence binding proteinImmune responseImmune systemIn VitroInfectionInflammationInflammatory ResponseInflammatory Response PathwayInterferonsJointsLeadLightMediatingMusMyositisPML genePathogenesisPlayRheumatoid ArthritisRoleRoss river virusSignal PathwaySindbis VirusSmall Interfering RNAStagingStructural ProteinSystemTRIM MotifTestingTherapeutic InterventionVenezuelan Equine Encephalitis VirusViralViral Structural ProteinsVirusVirus DiseasesVirus Replicationbasehuman TRIM25 proteinin vivointerestmacrophagemouse modelnovel therapeutic interventionoverexpressionpathogenresearch studyviral RNAvirus pathogenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Arthritic alphaviruses, such as Chikungunya virus (CHIKV) and Ross River virus (RRV) cause severe acute and persistent arthritis and myositis in infected humans and are significant emerging disease threats. A growing body of evidence suggests that CHIKV and related viruses have a complex interplay with the host innate immune response, where the type I IFN system is required for control of viral replication, but an overactive host inflammatory response contributes to virus-induced disease. Therefore, in order to develop new therapeutic approaches for these important human pathogens, it is essential that we have a better understanding of how these pathogens interact with the innate immune system. Tripartite motif- containing (TRIM) family members are key players in the host innate immune system, where TRIMs can act as antiviral effector molecules, modulate the type I IFN induction/signaling pathway, or regulate the host inflammatory response. We were interested in determining whether TRIM family members contribute to the control or exacerbation of alphavirus-induced inflammatory arthritis and found that several TRIM family members, including TRIM21 and TRIM34 were significantly upregulated in the joints of mice suffering from either RRV or CHIKV- induced arthritis. Furthermore, a combination of over expression assays and siRNA mediated knockdown studies indicate that both TRIM21 and TRIM34 have antiviral activity against CHIKV and RRV, but not against two other alphaviruses, Sindbis virus and Venezuelan equine encephalitis virus (VEEV), suggesting that TRIM21 and TRIM34 specifically interact with a subset of related alphaviruses. Based on these preliminary results, we propose to utilize a combination of in vitro and in vivo approaches to investigate the mechanism(s) by which TRIM21 and TRIM34 inhibit CHIKV/RRV replication and assessTRIM21's role in regulating the CHIKV induced inflammatory response in a mouse model of CHIKV-induced arthritis. These studies will elucidate the mechanisms underlying the anti-alphavirus activities of TRIM21 and TRIM34, shed new light on the mechanisms regulating alphavirus-induced arthritis, and may ultimately lead to the development of new therapies aimed at inhibiting the replication of CHIKV and related viruses or modulating the virus-induced inflammatory response. Relevance: Arthritic alphaviruses such as chikungunya virus (CHIKV) and Ross River virus (RRV) are significant emerging disease threats, yet we know relatively little about how these viruses induce disease or how the host innate immune response controls their spread. The proposed studies, which will evaluate the role of tripartite motif-containing (TRIM) family members in controlling CHIKV and RRV replication and the virus-induced inflammatory response, have the potential to expand our understanding of how arthritic alphaviruses interact with the host innate immune system and may identify new targets for therapeutic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Broad Spectrum Direct Acting Antivirals Against Emerging Alphaviruses
-
批准号:10513688
-
项目类别:
-
资助金额:$710.04万
-
财政年份:2022
-
负责人:Mark T Heise
-
依托单位:
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross
-
批准号:10238910
-
项目类别:
-
资助金额:$42.09万
-
财政年份:2012
-
负责人:Mark T Heise
-
依托单位:
Pathogenesis of Chikungunya virus
-
批准号:8375894
-
项目类别:
-
资助金额:$21.32万
-
财政年份:2012
-
负责人:Mark T Heise
-
依托单位:
TRIM Interactions with Arthritic Alphaviruses
-
批准号:8249185
-
项目类别:
-
资助金额:$21.89万
-
财政年份:2012
-
负责人:Mark T Heise
-
依托单位:
Pathogenesis of Chikungunya virus
-
批准号:8234196
-
项目类别:
-
资助金额:$20.15万
-
财政年份:2011
-
负责人:Mark T Heise
-
依托单位:
Pathogenesis of Chikungunya virus
-
批准号:7671949
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2009
-
负责人:Mark T Heise
-
依托单位:
Togavirus Tropism for Bones, Joints, and CNS
-
批准号:7928648
-
项目类别:
-
资助金额:$21.55万
-
财政年份:2009
-
负责人:Mark T Heise
-
依托单位:
Improved Vaccines for Rift Valley Fever Virus
-
批准号:7473550
-
项目类别:
-
资助金额:$47.3万
-
财政年份:2008
-
负责人:Mark T Heise
-
依托单位:
Improved Vaccines for Rift Valley Fever Virus
-
批准号:7586676
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2008
-
负责人:Mark T Heise
-
依托单位:
Improved Vaccines for Rift Valley Fever Virus
-
批准号:7787472
-
项目类别:
-
资助金额:$45.64万
-
财政年份:2008
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:7372970
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:7728264
-
项目类别:
-
资助金额:$28.89万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Arbovirus Evasion of Type I Interferon Induction
-
批准号:7380005
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Arbovirus Evasion of Type I Interferon Induction
-
批准号:7202170
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:8196845
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:7994179
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:7531806
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Core-- Animal Models
-
批准号:6915414
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2004
-
负责人:Mark T Heise
-
依托单位:
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS
-
批准号:6375362
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2000
-
负责人:Mark T Heise
-
依托单位:
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS
-
批准号:6190150
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2000
-
负责人:Mark T Heise
-
依托单位:
海外基金